Meeting to be held in London and Zurich on March 31-April 2 hosted by Cantor Fitzgerald.Light Up your Portfolio with Spark:Easily identify ...

Whilst it may not be a huge deal, we thought it was good to see that the Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Independent Director, John Bode, recently bought US$80k worth of stock, for US$7.96 ...

It’s been just six months since Zevra Therapeutics scored an FDA nod for Miplyffa as the first approved treatment for the rare lysosomal storage disorder Niemann-Pick disease type C (NPC), but ...

Zevra Therapeutics (NASDAQ:ZVRA – Get Free Report) will likely be announcing its earnings results before the market opens on ...

CELEBRATION, Fla. (AP) — CELEBRATION, Fla. (AP) — Zevra Therapeutics, Inc. (ZVRA) on Tuesday reported a loss of $35.7 million in its fourth quarter. The Celebration, Florida-based company said it had ...

(AP) — Zevra Therapeutics ... Zacks Investment Research was for a loss of 39 cents per share. The specialty pharmaceutical company posted revenue of $12 million in the period, exceeding Street ...

Q4 2024 Earnings Call Transcript March 11, 2025 Zevra Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.67 EPS, expectations were $-0.39. Operator: Good afternoon, and thank you ...

Neil Mcfarlane; President, Chief Executive Officer, Director; Zevra Therapeutics Inc Joshua Schafer; Chief Commercial Officer and Executive Vice President, Business Development; Zevra Therapeutics ...